ImmunoCellular Therapeutics Ltd. (IMUC) Gained 6.06% or 0.02 To Price $0.33 On Wednesday


ImmunoCellular Therapeutics Ltd. (IMUC) gained 6.06% or 0.02 to $0.33. It is around 2.32 million shares traded, which is 54.41% compare to the average total volume 4.26 million. The market cap of IMUC is $11.52 million. The year to date change is -84.09%. The 52 week price range is from $0.17 to $4.27. Price of IMUC have changed -0.45% during last week. It have changed 2.19% over last month, -10.00% over last 3 months, -65.71% over last 6 months and -85.91% over one year.

Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for IMUC is 0.33. The 200-day Moving Averages for IMUC is 0.98. It is 196.97% above current price. The 52-week High is 4.27. It is 1193.94% from the current price. The 52-week Low is 0.17. It is -48.48% from current price.

Some people may be interesting about short interest ratio of a stock. The short interest ratio of IMUC is 1.39 on 2017-11-30. Short % to float is 5.04%. There are some statistics of IMUC. It is has market cap $11.52 million. The share outstanding is 35.20 million. The average volume is 4.26 million. The percent of top 15 Institution holding is 9.90%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of IMUC is -403.02%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of IMUC is -154.35%.


Tags:

Share this post